Corey Best, MBA, CBE, PMP
Black Venture Institute Fellow (Cohort 4) at BLCK VC- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Black Corporate Board Readiness
Silicon Valley Executive CenterApr, 2023- Nov, 2024 -
Independent Director Initiative (Inaugural Cohort)
VC UniversityAug, 2022- Nov, 2024 -
Black Venture Institute
UC Berkeley Executive EducationJun, 2022- Nov, 2024 -
Python Data Structures
Coursera Course CertificatesMay, 2018- Nov, 2024 -
Programming for Everybody (Getting Started with Python)
CourseraApr, 2018- Nov, 2024 -
Certified Blockchain Expert
Blockchain CouncilMar, 2018- Nov, 2024 -
Project Management Professional (PMP)®
Project Management InstituteMay, 2011- Nov, 2024
Experience
-
BLCK VC
-
United States
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Black Venture Institute Fellow (Cohort 4)
-
Jun 2022 - Present
Black Venture Institute (BVI) is a selective curriculum-based program for Black operators and technology executives who will represent the future of Black fund managers, angel and venture investors across the country. Co-hosted by the Berkeley Haas School of Business and Berkeley Executive Education, BVI is a growing community of 220 BVI fellows. Black Venture Institute (BVI) is a selective curriculum-based program for Black operators and technology executives who will represent the future of Black fund managers, angel and venture investors across the country. Co-hosted by the Berkeley Haas School of Business and Berkeley Executive Education, BVI is a growing community of 220 BVI fellows.
-
-
-
Cap Table Coalition
-
United States
-
Investment Management
-
1 - 100 Employee
-
Investor
-
Jan 2022 - Present
The Cap Table Coalition (CTC) aims to diversify the VC ecosystem by creating investment opportunities for Black, Latinx, LGBTQ+, Native American, women, and other traditionally marginalized investors. The Cap Table Coalition (CTC) aims to diversify the VC ecosystem by creating investment opportunities for Black, Latinx, LGBTQ+, Native American, women, and other traditionally marginalized investors.
-
-
-
Sobi - North America
-
United States
-
Biotechnology Research
-
200 - 300 Employee
-
Senior Director, North American Study Operations
-
Jan 2021 - Present
Member of the North American Medical Leadership Team who leads operational execution of North American observational studies and supports Global R&D studies with North American sites.• Member of RWE/HEOR team that works across Medical Affairs while collaborating with Commercial and R&D colleagues• Develops and executes plans, forecasts, and budgets for North American clinical and observational studies• Establishes metrics and reports for North American observational studies• Leads identification, selection, contracting, and performance management of relevant vendors• Works in alignment with Global R&D for global clinical studies with North American sites Show less
-
-
Director of Clinical Operations
-
Sep 2020 - Jan 2021
Clinical Liaison for North America Medical Affairs. Directly involved in all aspects of study conduct and supports the acceleration of site identification, activation, and subject enrollment. Worked with the designated CRO across the functional disciplines. Facilitated the flow of communication between the Global Study Team, North America Medical Affairs, the CRO, vendors, and sites.• Coordinated with Medical Affairs support (e.g. study training, global and local study processes, and compliance) for clinical studies performed in the US• Assisted with planning of observational studies while establishing operational strategy• Ensured execution of CRO deliverables and timelines• Communicated effectively with company leadership and European team members regarding critical clinical operations needs Show less
-
-
-
Linqto
-
United States
-
Financial Services
-
1 - 100 Employee
-
Investor
-
Jul 2020 - Present
Linqto helps you identify, evaluate and invest in the world's leading Unicorns. Linqto makes private securities investing more accessible, affordable and efficient. Linqto helps you identify, evaluate and invest in the world's leading Unicorns. Linqto makes private securities investing more accessible, affordable and efficient.
-
-
-
Biogen
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Clinical Operations Lead III
-
Mar 2019 - Sep 2020
Partnered with Medical Research and other functions to develop operationally feasible and clear protocol concepts and final protocols. Leveraged phase and operational expertise to establish study level operational strategy in alignment with the Clinical Development Plan (CDP) and program level strategy. Independently oversaw clinical studies by establishing the operational strategy and securing excellence in execution through the CRO partner. • Developed scientifically robust, operationally feasible, and clear protocols ▪ Leveraged appropriate ongoing data review to identify and mitigate patient safety, study design, data integrity, and study conduct issues ▪ Ensured all operational aspects support end point integrity and data validity ▪ Oversaw tactical execution of the operational strategy crafted for the CRO while ensuring the appropriate risk mitigation plans in place to facilitate oversight issue identification and resolution ▪ Chaired Study Management Team meetings and drove effective and efficient team operations through communication, goal setting, and strategy implementation Show less
-
-
-
Athenex
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Associate Director of Clinical Operations and Program Management
-
Nov 2016 - Mar 2019
Led or participated in the strategy and execution of all clinical and regulatory efforts – from conception to completion – across multiple functions for one of company’s primary assets. Acted as key operational interface accountable for all aspects of clinical trial conduct, including program and project management, outsourcing, monitoring, clinical compliance, data management and interactions with investigators.• As Clinical Program Lead oversaw management of Clinical Research Organizations (CROs) and internal study team while collaborating with other functional areas (Clinical Pharmacology, Data Management, Pharmacovigilance, Regulatory, Clinical Manufacturing, Clinical Supplies, Finance, Quality Assurance and Commercialization) to achieve corporate goals while ensuring quality, timelines and efficiency for a $100 million program▪ Collaborated with MDs to produce a well-structured Clinical Development Plan (CDP) that anticipated the entire clinical development lifecycle and its goals▪ Worked closely with MDs (while also communicating with the CMO and VP of Clinical) to drive strategy for program while ensuring the team was able to implement tactical plans from the CDP Show less
-
-
Senior Management Consultant - Clinical Operations and Program Management
-
Mar 2016 - Oct 2016
I was accountable for all aspects of clinical trial conduct including program and project management, monitoring, clinical compliance, data management and interactions with Investigators. After seven months, I was invited to join the organization as an Associate Director and provided management oversight of program budgets as well as optimization of resource allocation and process improvement initiatives including SOPs and systems integration.
-
-
-
Otsuka Pharmaceutical Companies (U.S.)
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Global Senior Manager
-
Jun 2011 - Jan 2015
I provided leadership and operational excellence within early development trials with the responsibility for leveraging talent, maximizing performance and guiding professional development of a team. I led the global implementation of a $10M pediatric development program with a team of over 25 internal and external parties to gain regulatory approval from European Medicinal Agency for a novel anti-tuberculosis compound. I provided effective oversight and project management of outsourced activities including vendor selection, contract management, and tactical communication which led to timely study completion, favorable treatment outcome for 75% of trial participants, significant reduction in mortality, and minimal audit findings by European Medicines Agency. Show less
-
-
Global Clinical Development Manager
-
Jun 2008 - Jun 2011
I led and managed logistics and tactical execution for drug resistant program with a team of over 100 internal and external parties, and provided input into development and implementation of project strategy for a clinical program with a budget of $60M. Worked with senior leadership to design an organizational structure for a new research institute to allow for early development of tuberculosis disease management franchise in SE Asia and demonstrated ability to comfortably deal with ambiguity by adapting to the decision to no longer pursue the Center of Research Excellence concept. Show less
-
-
Global Senior Clinical Research Associate
-
Aug 2007 - Jun 2008
I served as Lead CRA for a pivotal Phase II trial and extension study as well as Regional Lead for two regions in Asia. During my time as Regional Lead I anticipated study conduct issues and assisted in developing contingency plans prior to initiation and throughout life of trial.
-
-
Regional Senior Clinical Research Associate
-
Nov 2004 - Aug 2007
I served as primary contact with vendors for management of daily operations on assigned protocols for global studies. I planned, organized, communicated and implemented study objectives for assigned protocols in conjunction with CRO, SMO, and other vendors.
-
-
-
PPD
-
United States
-
Research Services
-
700 & Above Employee
-
Associate Project Manager
-
Aug 2003 - Nov 2004
I participated in Project Team and Executive Review Meetings to communicate progress of studies, quality and operational issues. I participated in Project Team and Executive Review Meetings to communicate progress of studies, quality and operational issues.
-
-
-
Otsuka Pharmaceutical Companies (U.S.)
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Lead Clinical Research Associate
-
Jun 2002 - Aug 2003
I performed in-house clinical review of CRF’s, generated and resolved queries, and reviewed data table and listings. I performed in-house clinical review of CRF’s, generated and resolved queries, and reviewed data table and listings.
-
-
-
PPD
-
United States
-
Research Services
-
700 & Above Employee
-
Regional Senior Clinical Research Associate
-
Oct 2001 - May 2002
I served as primary contact with investigative sites that conducted trials and acted as liaison between the Sponsor and PPD.
-
-
Regional Clinical Research Associate II
-
Sep 2000 - Oct 2001
I conducted site visits to determine protocol and regulatory compliance, as well as prepared required documentation.
-
-
Clinical Research Associate
-
Aug 1999 - Sep 2000
I evaluated, initiated, monitored, closed out sites according to SOPs and FDA guidelines.
-
-
Education
-
Duke University
Master of Business Administration (MBA) -
Campbell University
Masters of Science, Clinical Research -
Campbell University
Bachelor of Science, Pharmaceutical Sciences -
University of North Carolina at Chapel Hill
Certificate in Core Public Health Concepts -
University of North Carolina at Chapel Hill
Emerging Leaders in Public Health Fellowship -
Center of Creative Leadership
Looking Glass Experience -
ELC Strengthening the Pipeline 2012
Community
